Eight Advisory supported SERB Pharmaceuticals and Charterhouse Capital Partners on their acquisition of RSDL®
Eight Advisory and Eight Advisory Avocats provided financial and tax due diligence services to SERB Pharmaceuticals and its majority shareholder Charterhouse Capital Partners in the context of their acquisition of RSDL® (Reactive Skin Decontamination Lotion).
Eight Advisory team members supporting on this transaction:
- Financial due diligence: Gennat Mouline (Partner), Julien Roux (Director) and Jean-Baptiste Juszezak (Manager)
Eight Advisory Avocats team members supporting on this transaction:
- Tax due diligence: Guillaume Rembry (Partner-Attorney at law), Guillaume Exerjean (Attorney at law) and Lucie Goeller (Attorney at law)
Corporate News
Rolling Forecast: Cash flow forecasts and budgeting finally converging?
13 Jun 2025
Read more
Deals
Eight Advisory and Eight Advisory Avocats assisted the Delabie group in its acquisition of the KWC Professional group
13 Jun 2025
Read more
Corporate News
Defence: France launches nationwide drive to arm its defence industry with capital
11 Jun 2025
Read more
Deals
Eight Advisory supported Harmonie Mutuelle on its acquisition of NoveoCare
10 Jun 2025
Read more